Shorter sleep duration and both regular and occasional snoring are linked to an increased risk for type 2 diabetes in women with a history of gestational diabetes.
Imaging techniques are enhancing our understanding of the myocardial microcirculation and providing insights into the early stages of microvascular dysfunction in people with diabetes.
Increased risk for nonarteritic anterior ischemic optic neuropathy associated with semaglutide treatment in people with type 2 diabetes is not as great as previously reported.
Berberine ursodeoxycholate, a gut–liver anti-inflammatory metabolic modulator, significantly reduces HbA1c and improves hepatic and cardiometabolic parameters in people with type 2 diabetes.
Recommendations proposed to reduce glycemic variability and improve glycemic management in people with type 1 diabetes, focusing on physical activity, dietary habits, insulin therapy, and other causes of increased variability.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
Complete heterozygous deletion of HNF1B was incidentally discovered in a woman who was enrolled in a clinical trial for type 1 diabetes and received immunosuppressive treatment for 4 years when she was a child.
Semaglutide therapy achieved weight loss and reduced cocaine craving in a man with obesity and chronic cocaine abuse. Could this be a new strategy to address substance craving in patients with comorbid obesity?
Adding empagliflozin to sulfonylurea improved glycemic control in a woman with maturity-onset diabetes of the young. No adverse effects were noted, including no increase in ketonemia or ketonuria.
Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.
Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
Type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) are characterized by insufficient insulin secretion and insulin resistance, respectively. Both conditions require the restoration of islet cell function and maintenance of higher …
Performing regular physical activity (PA) throughout the lifespan, including during a woman’s preconception years (defined as the time period in which women desire and intend to conceive a child; Hill et al., 2020 ), is critical for overall health …
In the past three decades, the prevalence of obesity in adults increased in almost every country among both females and males [ 1 ]. During this time, the age-standardized prevalence of obesity rose by more than 20% points in 49 countries (25% of …
Combination therapy is a cornerstone of modern type 2 diabetes management, extending beyond traditional goals of glucose, blood pressure, and lipid control to focus on therapies protecting the heart and kidneys. The introduction of sodium-glucose …
Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.
Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
Sporadic Alzheimer’s disease is a progressive neurodegenerative disorder affecting the central nervous system. Its main two hallmarks are extracellular deposition of aggregated amyloid beta resulting in senile plaques and intracellular …
Type 2 diabetes (T2D) is a major cause of chronic kidney disease (CKD) worldwide [ 1 , 2 ]. Diabetes with CKD is the most common underlying cause of kidney failure, accounting for almost 50% of cases in the developed world [ 3 ]. Additionally …
Type 2 diabetes (T2D) is a global epidemic. In 2021, nearly 11% of the world’s population had T2D, contributing to more than 6.7 million deaths [ 1 ]. The Middle East and North Africa (MENA) region has the highest regional prevalence of T2D at …
Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes diagnosed within the first 6 months of life [ 1 ]. It is a rare disease with a global incidence that varies, with the highest rate reported among the highly consanguineous Arab …
